Product Name

  • Name

    Candesartan cilexetil

  • EINECS 627-030-2
  • CAS No. 145040-37-5
  • Article Data41
  • CAS DataBase
  • Density 1.37 g/cm3
  • Solubility
  • Melting Point 168-170?C
  • Formula C33H34N6O6
  • Boiling Point 843.3 ºC at 760 mmHg
  • Molecular Weight 610.67
  • Flash Point 463.8 ºC
  • Transport Information
  • Appearance White crystalline powder
  • Safety 26-36
  • Risk Codes 20/21/22-36/37/38
  • Molecular Structure Molecular Structure of 145040-37-5 (Candesartan cilexetil)
  • Hazard Symbols HarmfulXn
  • Synonyms 1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2-(1H-tetrazol-5-yl)(1,1-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-;TCV-116;Atacand;Atacand (TN);1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzoimidazole-4-carboxylate;TCV 116;Candesartancilexetil;
  • PSA 143.34000
  • LogP 6.31910

Synthetic route

cilexetil trityl candesartan
170791-09-0

cilexetil trityl candesartan

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With hydrogenchloride In methanol; dichloromethane at -14 - -12℃; Temperature; Flow reactor; Large scale;98%
With iron(III) chloride In methanol; dichloromethane at 23℃; for 48h; Time; Reagent/catalyst;96%
With methanol; zinc(II) chloride In butanone at 20 - 40℃; for 2.5h; Product distribution / selectivity;95.23%
orthocarbonic acid tetraethyl ester
78-09-1

orthocarbonic acid tetraethyl ester

2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-aminobenzoic acid-1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
1236156-65-2

2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-aminobenzoic acid-1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With acetic acid In ethyl acetate at 30℃; Temperature;93.9%
With acetic acid In toluene at 60℃; for 2h;81%
orthocarbonic acid tetraethyl ester
78-09-1

orthocarbonic acid tetraethyl ester

C30H32N6O5*C2H2O4

C30H32N6O5*C2H2O4

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Stage #1: C30H32N6O5*C2H2O4 With potassium carbonate In ethyl acetate at 10 - 15℃; pH=6 - 7;
Stage #2: orthocarbonic acid tetraethyl ester In acetic acid at 0 - 25℃; for 15h;
92.3%
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 1-({4-[2-(1-benzyl-1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-2-ethoxy-1H-1,3-benzodiazole-7-carboxylate
1307853-85-5

1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 1-({4-[2-(1-benzyl-1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-2-ethoxy-1H-1,3-benzodiazole-7-carboxylate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With 5% palladium on barium sulphate; ammonium formate In water; isopropyl alcohol at 25℃; for 14h; Temperature; Time;92.1%
With 5% palladium on barium sulphate; ammonium formate In water; isopropyl alcohol at 25℃; for 14h;80%
With ammonium formate; palladium over charcoal In water; isopropyl alcohol at 55 - 60℃; for 12 - 15h;
With rosenmund catalyst; ammonium formate In water; isopropyl alcohol
1N-HCl

1N-HCl

cilexetil trityl candesartan
170791-09-0

cilexetil trityl candesartan

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With sodium bicarbonate In methanol; dichloromethane; water; ethyl acetate75%
2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid
139481-72-4

2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With water In methanol; toluene for 2 - 4h; Product distribution / selectivity; Heating / reflux;67%
C41H42N6O7
1307853-79-7

C41H42N6O7

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With ammonium formate; 5%-palladium/activated carbon In water; isopropyl alcohol at 40 - 50℃; for 17h;55%
2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid
139481-72-4

2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid

1N-HCl

1N-HCl

cyclohexyl (1-iodoethyl)carbonate
95789-69-8, 102672-57-1

cyclohexyl (1-iodoethyl)carbonate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With potassium carbonate In methanol; ethanol; water; N,N-dimethyl-formamide
methanolic hydrogen chloride

methanolic hydrogen chloride

cilexetil trityl candesartan
170791-09-0

cilexetil trityl candesartan

octanol
111-87-5

octanol

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With hydrogenchloride In methanol; ethanol; hexane; dichloromethane; water; acetone
cilexetil trityl candesartan
170791-09-0

cilexetil trityl candesartan

A

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate
869631-11-8

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate

B

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With methanol for 24h; Product distribution / selectivity; Heating / reflux;
With methanol; formic acid In dichloromethane at 25℃; for 5 - 23h; Product distribution / selectivity;
Stage #1: cilexetil trityl candesartan With methanol; water; zinc(II) chloride for 2.5h; Heating / reflux;
Stage #2: With water; sodium hydrogencarbonate In methanol at 20℃; pH=6.11; Product distribution / selectivity;
2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)methyl]-1H-benzimidazole-7-carboxylicacid-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
632322-62-4

2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)methyl]-1H-benzimidazole-7-carboxylicacid-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With azido tributyltin (IV) In toluene for 52.5h; Heating / reflux;
1-chloroethyl cyclohexyl carbonate
99464-83-2

1-chloroethyl cyclohexyl carbonate

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

candesartan
139481-59-7

candesartan

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Stage #1: tert-butyldimethylsilyl chloride; candesartan With triethylamine In chloroform at 20℃; for 3h;
Stage #2: 1-chloroethyl cyclohexyl carbonate With triethylamine In chloroform for 24h;
candesartan
139481-59-7

candesartan

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: triethylamine / dichloromethane / 3.75 h / 25 - 35 °C
2.1: potassium carbonate / N,N-dimethyl-formamide / 2.5 h / 60 - 65 °C
3.1: formic acid; methanol / dichloromethane / 7 h / 30 - 35 °C
3.2: 0.33 h / 15 - 20 °C
View Scheme
Multi-step reaction with 3 steps
1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
2: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
3: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
Multi-step reaction with 3 steps
1: triethylamine / dichloromethane / 3.5 h / 15 - 23 °C / Flow reactor; Large scale
2: potassium carbonate / N,N-dimethyl-formamide / 4 h / 60 °C / Flow reactor; Alkaline conditions; Large scale
3: hydrogenchloride / dichloromethane; methanol / -14 - -12 °C / Flow reactor; Large scale
View Scheme
methyl 2-carboxy-3-nitrobenzoate
21606-04-2

methyl 2-carboxy-3-nitrobenzoate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: N,N-dimethyl-formamide; thionyl chloride / toluene / 2.5 h / 75 °C
2.1: sodium azide; tetrabutylammomium bromide / toluene / 4 h / -10 - -5 °C
2.2: 1 h / 80 - 85 °C
3.1: potassium carbonate; tetrabutylammomium bromide / toluene / 12 h / 80 - 85 °C
3.2: 3 h / Reflux
4.1: tin(ll) chloride / ethyl acetate / 1.5 h / Reflux
4.2: 4.5 h / -10 - 0 °C
4.3: 0.5 h / Reflux
5.1: acetic acid / toluene / 6 h / Reflux
6.1: sodium azide; tributyltin chloride / toluene / 100 h / Reflux
6.2: 0 - 20 °C
7.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
7.2: 3 h / 0 °C / pH 4
8.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
9.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
10.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
Multi-step reaction with 8 steps
1.1: triethylamine; diphenyl phosphoryl azide / N,N-dimethyl-formamide / 20 - 31 °C / Inert atmosphere
1.2: 9 h / 85 - 87 °C
1.3: 3 h / 50 - 55 °C
2.1: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
3.1: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
4.1: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
5.1: acetic acid / 1 h / 90 °C
6.1: sodium hydroxide / methanol / 2 h / 90 °C
7.1: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
8.1: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
methyl 2-(N-tert-butoxycarbonylamino)-3-nitrobenzoate
57113-90-3

methyl 2-(N-tert-butoxycarbonylamino)-3-nitrobenzoate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: potassium carbonate; tetrabutylammomium bromide / toluene / 12 h / 80 - 85 °C
1.2: 3 h / Reflux
2.1: tin(ll) chloride / ethyl acetate / 1.5 h / Reflux
2.2: 4.5 h / -10 - 0 °C
2.3: 0.5 h / Reflux
3.1: acetic acid / toluene / 6 h / Reflux
4.1: sodium azide; tributyltin chloride / toluene / 100 h / Reflux
4.2: 0 - 20 °C
5.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
5.2: 3 h / 0 °C / pH 4
6.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
7.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
8.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
Multi-step reaction with 7 steps
1: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
2: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
3: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
4: acetic acid / 1 h / 90 °C
5: sodium hydroxide / methanol / 2 h / 90 °C
6: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
7: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
methyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate
139481-69-9

methyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
1.2: 3 h / 0 °C / pH 4
2.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
3.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
4.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
methyl 3-amino-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]benzoate
136304-78-4

methyl 3-amino-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]benzoate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: acetic acid / toluene / 6 h / Reflux
2.1: sodium azide; tributyltin chloride / toluene / 100 h / Reflux
2.2: 0 - 20 °C
3.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
3.2: 3 h / 0 °C / pH 4
4.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
5.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
6.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
3-nitrophthalic acid
603-11-2

3-nitrophthalic acid

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: sulfuric acid / 24.75 h / 20 - 65 °C
2.1: N,N-dimethyl-formamide; thionyl chloride / toluene / 2.5 h / 75 °C
3.1: sodium azide; tetrabutylammomium bromide / toluene / 4 h / -10 - -5 °C
3.2: 1 h / 80 - 85 °C
4.1: potassium carbonate; tetrabutylammomium bromide / toluene / 12 h / 80 - 85 °C
4.2: 3 h / Reflux
5.1: tin(ll) chloride / ethyl acetate / 1.5 h / Reflux
5.2: 4.5 h / -10 - 0 °C
5.3: 0.5 h / Reflux
6.1: acetic acid / toluene / 6 h / Reflux
7.1: sodium azide; tributyltin chloride / toluene / 100 h / Reflux
7.2: 0 - 20 °C
8.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
8.2: 3 h / 0 °C / pH 4
9.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
10.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
11.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
methyl 2-<<2'-cyanobiphenyl-4-yl)methyl>amino>-3-nitrobenzoate
139481-28-0

methyl 2-<<2'-cyanobiphenyl-4-yl)methyl>amino>-3-nitrobenzoate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: tin(ll) chloride / ethyl acetate / 1.5 h / Reflux
1.2: 4.5 h / -10 - 0 °C
1.3: 0.5 h / Reflux
2.1: acetic acid / toluene / 6 h / Reflux
3.1: sodium azide; tributyltin chloride / toluene / 100 h / Reflux
3.2: 0 - 20 °C
4.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
4.2: 3 h / 0 °C / pH 4
5.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
6.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
7.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
acid chloride of 1-methylhydrogen-3-nitrophthalate
73833-13-3

acid chloride of 1-methylhydrogen-3-nitrophthalate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: sodium azide; tetrabutylammomium bromide / toluene / 4 h / -10 - -5 °C
1.2: 1 h / 80 - 85 °C
2.1: potassium carbonate; tetrabutylammomium bromide / toluene / 12 h / 80 - 85 °C
2.2: 3 h / Reflux
3.1: tin(ll) chloride / ethyl acetate / 1.5 h / Reflux
3.2: 4.5 h / -10 - 0 °C
3.3: 0.5 h / Reflux
4.1: acetic acid / toluene / 6 h / Reflux
5.1: sodium azide; tributyltin chloride / toluene / 100 h / Reflux
5.2: 0 - 20 °C
6.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
6.2: 3 h / 0 °C / pH 4
7.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
8.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
9.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
methyl 1-[(2-cyanobiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate

methyl 1-[(2-cyanobiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: sodium azide; tributyltin chloride / toluene / 100 h / Reflux
1.2: 0 - 20 °C
2.1: sodium hydroxide; water / ethanol / 3.5 h / Reflux
2.2: 3 h / 0 °C / pH 4
3.1: triethylamine / dichloromethane / 8 h / 0 - 20 °C
4.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 2 h / 75 °C
5.1: hydrogen / palladium 10% on activated carbon / toluene; methanol / 20 °C / 2280.15 Torr
View Scheme
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(N-triphenylmethyltetrazole-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate

1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(N-triphenylmethyltetrazole-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In methanol; toluene at 20℃; under 2280.15 Torr; Product distribution / selectivity;
benzoyl chloride
98-88-4

benzoyl chloride

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: triethylamine / tetrahydrofuran / 7 - 16 °C
2.1: phosphorus pentachloride / dichloromethane / -11 - 19 °C
2.2: 7 h / -6 - 20 °C
3.1: potassium carbonate; triphenylphosphine / dichloro(1,5-cyclooctadiene)ruthenium(II) polymer / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C / Inert atmosphere
4.1: sodium methylate / methanol / 1.5 h / 20 °C
5.1: phosphorus tribromide / tetrahydrofuran / 5.5 h / 0 - 20 °C
6.1: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
7.1: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
8.1: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
9.1: acetic acid / 1 h / 90 °C
10.1: sodium hydroxide / methanol / 2 h / 90 °C
11.1: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
12.1: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
4-bromobenzyl acetate
21388-92-1

4-bromobenzyl acetate

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: potassium carbonate; triphenylphosphine / dichloro(1,5-cyclooctadiene)ruthenium(II) polymer / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C / Inert atmosphere
2: sodium methylate / methanol / 1.5 h / 20 °C
3: phosphorus tribromide / tetrahydrofuran / 5.5 h / 0 - 20 °C
4: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
5: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
6: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
7: acetic acid / 1 h / 90 °C
8: sodium hydroxide / methanol / 2 h / 90 °C
9: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
10: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
4-bromobenzenemethanol
873-75-6

4-bromobenzenemethanol

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1: dmap; triethylamine / tetrahydrofuran / 15 - 30 °C
2: potassium carbonate; triphenylphosphine / dichloro(1,5-cyclooctadiene)ruthenium(II) polymer / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C / Inert atmosphere
3: sodium methylate / methanol / 1.5 h / 20 °C
4: phosphorus tribromide / tetrahydrofuran / 5.5 h / 0 - 20 °C
5: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
6: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
7: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
8: acetic acid / 1 h / 90 °C
9: sodium hydroxide / methanol / 2 h / 90 °C
10: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
11: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
5-Phenyl-1H-tetrazole
18039-42-4

5-Phenyl-1H-tetrazole

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: sodium carbonate; tetrabutylammomium bromide / chloroform; water / 2 h / 55 °C / Cooling with ice
1.2: 1 h
2.1: potassium carbonate; triphenylphosphine / dichloro(1,5-cyclooctadiene)ruthenium(II) polymer / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C / Inert atmosphere
3.1: sodium methylate / methanol / 1.5 h / 20 °C
4.1: phosphorus tribromide / tetrahydrofuran / 5.5 h / 0 - 20 °C
5.1: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
6.1: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
7.1: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
8.1: acetic acid / 1 h / 90 °C
9.1: sodium hydroxide / methanol / 2 h / 90 °C
10.1: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
11.1: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
Multi-step reaction with 11 steps
1: sodium carbonate; tetrabutylammomium bromide / chloroform; water / 2 h / 55 °C / Cooling with ice
2: potassium carbonate; triphenylphosphine / dichloro(1,5-cyclooctadiene)ruthenium(II) polymer / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C / Inert atmosphere
3: sodium methylate / methanol / 1.5 h / 20 °C
4: phosphorus tribromide / tetrahydrofuran / 5.5 h / 0 - 20 °C
5: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
6: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
7: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
8: acetic acid / 1 h / 90 °C
9: sodium hydroxide / methanol / 2 h / 90 °C
10: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
11: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
1-(p-methoxybenzyl)-5-phenyl-1H-tetrazole
512182-38-6

1-(p-methoxybenzyl)-5-phenyl-1H-tetrazole

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: potassium carbonate; triphenylphosphine / dichloro(1,5-cyclooctadiene)ruthenium(II) polymer / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C / Inert atmosphere
2: sodium methylate / methanol / 1.5 h / 20 °C
3: phosphorus tribromide / tetrahydrofuran / 5.5 h / 0 - 20 °C
4: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
5: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
6: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
7: acetic acid / 1 h / 90 °C
8: sodium hydroxide / methanol / 2 h / 90 °C
9: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
10: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
N-(4-methoxybenzyl)benzamide
41882-10-4

N-(4-methoxybenzyl)benzamide

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: phosphorus pentachloride / dichloromethane / -11 - 19 °C
1.2: 7 h / -6 - 20 °C
2.1: potassium carbonate; triphenylphosphine / dichloro(1,5-cyclooctadiene)ruthenium(II) polymer / 1-methyl-pyrrolidin-2-one / 2 h / 140 °C / Inert atmosphere
3.1: sodium methylate / methanol / 1.5 h / 20 °C
4.1: phosphorus tribromide / tetrahydrofuran / 5.5 h / 0 - 20 °C
5.1: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
6.1: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
7.1: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
8.1: acetic acid / 1 h / 90 °C
9.1: sodium hydroxide / methanol / 2 h / 90 °C
10.1: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
11.1: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
5-[4'-(bromomethyl)biphenyl-2-yl]-1-(p-methoxybenzyl)-1H-tetrazole
1307853-40-2

5-[4'-(bromomethyl)biphenyl-2-yl]-1-(p-methoxybenzyl)-1H-tetrazole

candesartan cilexetil
145040-37-5

candesartan cilexetil

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: potassium carbonate / acetonitrile / 6 h / Reflux; Inert atmosphere
2: hydrogenchloride / methanol / 3.22 h / 3 - 9 °C
3: tin(II) chloride dihdyrate / methanol / 2 h / Reflux
4: acetic acid / 1 h / 90 °C
5: sodium hydroxide / methanol / 2 h / 90 °C
6: potassium carbonate / N,N-dimethyl-formamide / 4 h / 65 °C
7: ammonium formate / 5%-palladium/activated carbon / isopropyl alcohol; water / 17 h / 40 - 50 °C
View Scheme
candesartan cilexetil
145040-37-5

candesartan cilexetil

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate
869631-11-8

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate

Conditions
ConditionsYield
With hydrogenchloride; water In acetone for 6h; Reflux;87.9%
nebivolol
118457-16-2

nebivolol

candesartan cilexetil
145040-37-5

candesartan cilexetil

candensartan cilexetil-nebivolol salt

candensartan cilexetil-nebivolol salt

Conditions
ConditionsYield
In ethanol at 20 - 45℃; for 5h; Concentration; Solvent; Temperature; Time;81%
candesartan cilexetil
145040-37-5

candesartan cilexetil

methyl iodide
74-88-4

methyl iodide

1-(((cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2’-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

1-(((cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2’-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Conditions
ConditionsYield
In dichloromethane Reflux;79%
candesartan cilexetil
145040-37-5

candesartan cilexetil

A

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate
869631-11-8

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate

B

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
914613-35-7

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate

C

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
914613-36-8

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate

Conditions
ConditionsYield
at 55℃; for 336h; Product distribution / selectivity;
at 55℃; for 336h; Product distribution / selectivity;
candesartan cilexetil
145040-37-5

candesartan cilexetil

A

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate
869631-11-8

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate

B

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
914613-36-8

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate

Conditions
ConditionsYield
In ethanol at 50℃; for 31h; Product distribution / selectivity;
trityl chloride
76-83-5

trityl chloride

candesartan cilexetil
145040-37-5

candesartan cilexetil

cilexetil trityl candesartan
170791-09-0

cilexetil trityl candesartan

Conditions
ConditionsYield
With triethylamine for 1h; Heating / reflux;
ethyl iodide
75-03-6

ethyl iodide

candesartan cilexetil
145040-37-5

candesartan cilexetil

A

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
914613-35-7

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate

B

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
914613-36-8

(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate

Conditions
ConditionsYield
Stage #1: candesartan cilexetil With potassium carbonate In acetone at 20℃; for 1h; Inert atmosphere;
Stage #2: ethyl iodide In acetone at 20℃; for 24h;
A 2.5 g
B 2.9 g

Candesartan cilexetil Specification

1. Introduction of Candesartan cilexetil
Candesartan cilexetil is one kind of white or off white powder. The IUPAC Name of it is 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate. It belongs to Antihypertensive;API;APIs;Hypertension;Bases & Related Reagents;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals;Candesartan;Heterocycles. The Classification Code of it is Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antagonist [angiotensin II receptor]; Antihypertensive; Antihypertensive agents; Cardiovascular Agents; Drug / Therapeutic Agent.

2. Properties of Candesartan cilexetil
Physical properties about Candesartan cilexetil are:
(1)Index of Refraction: 1.666; (2)Molar Refractivity: 165.46 cm3; (3)Molar Volume: 444.6 cm3; (4)Surface Tension: 54 dyne/cm; (5)Density: 1.37 g/cm3; (6)Flash Point: 463.8 °C; (7)Enthalpy of Vaporization: 122.54 kJ/mol; (8)Boiling Point: 843.3 °C at 760 mmHg; (9)Vapour Pressure of Candesartan cilexetil: 1.11E-28 mmHg at 25 °C.

3. Structure Descriptors of Candesartan cilexetil
(1)SMILES: c1cc(c2c(c1)nc(OCC)n2Cc1ccc(cc1)c1ccccc1c1[nH]nnn1)C(O[C@@H](OC(OC1CCCCC1)=O)C)=O
(2)InChI: InChI=1/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)
(3)InChIKey: InChIKey=GHOSNRCGJFBJIB-UHFFFAOYSA-N

4. Toxicity of Candesartan cilexetil

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral > 2gm/kg (2000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 406, 2000.
mouse LD50 intraperitoneal 807mg/kg (807mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 24(Suppl,
mouse LD50 oral > 2gm/kg (2000mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 24(Suppl,
rat LD50 intraperitoneal 940mg/kg (940mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 24(Suppl,
rat LD50 oral > 2gm/kg (2000mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 24(Suppl,

5. Safety of Candesartan cilexetil
Hazard Codes: HarmfulXn
Risk Statements: 20/21/22-36/37/38 
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed. 
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements of Candesartan cilexetil (CAS NO.145040-37-5): 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36:Wear suitable protective clothing.

6. Uses of Candesartan cilexetil
Candesartan cilexetil (CAS NO.145040-37-5) is used in treatment of congestive heart failure. As an antihypertensive, it will be used in treatment of congestive heart failure.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View